Medications

Dose range for iberdomide studied in systemic lupus erythematosus

For patients with systemic lupus erythematosus (SLE), iberdomide at a higher dose is superior to placebo for the rate of response indicating reduction in disease activity, according to a study published in the March 17 issue ...

Diseases, Conditions, Syndromes

COVID-19 linked to risk of dangerous blood clots in stroke patients

Older stroke patients who had a history of COVID-19 were more likely to develop dangerous blood clots in the veins than those who did not have the coronavirus-driven disease, a new study from the Centers for Disease Control ...

page 26 from 40